Running and Senolytics Help Aging Mouse Hearts, but Don't Add Up
Graded Preliminary — a controlled experiment in 54 mice over nine months; the findings come from animals and have not been tested in people.
Animal study. Findings may not carry over to people, which is why the grade is capped at Preliminary.
- Design
- Animal study
- Participants
- 54
- Duration
- 9 months
- Funding
- Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian…
Treadmill running and senolytics each improved heart relaxation in aging mice, and combining them added no further benefit.
As hearts age, they relax more slowly and work less efficiently. In aging mice, regular running pushed back against that. So did senolytics, compounds meant to clear out aged cells that no longer divide. Combining the two, however, brought no extra benefit.
Researchers split 54 twelve-month-old mice into four groups at random. For nine months, the mice ran on a treadmill for 30 minutes twice a week, got the senolytics dasatinib and quercetin, got both, or got a dummy solution. By the end, hearts in all treated groups took less time to relax after each beat. The heart tissue held fewer cells carrying signs of cell aging. Pumping strength showed no clear difference between groups.
Across the whole heart, though, certain aging proteins and inflammatory messengers stayed unchanged. The authors also note that no single marker reliably identifies aged cells. So whether aged cells truly disappeared is uncertain. And these were mice, not people.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
